metastatic breast cancer
Showing NaN - NaN of 54
Metastatic Breast Cancer Trial in Worldwide (OPT-822/OPT-821(30 µg/100 µg), Phosphate Buffer Saline (PBS), Cyclophosphamide)
Completed
- Metastatic Breast Cancer
- OPT-822/OPT-821(30 μg/100 μg)
- +2 more
-
Birmingham, Alabama
- +42 more
Sep 14, 2020
Metastatic Breast Cancer Trial in Houston (Exemestane, Sutent)
Terminated
- Metastatic Breast Cancer
-
Houston, TexasBaylor College of Medicine, Lester and Sue Smith Breast Center
Jul 9, 2020
Metastatic Breast Cancer Trial in Worldwide (Pertuzumab, Placebo, Trastuzumab)
Metastatic Breast Cancer Trial in Houston (ABI-008 (nab-docetaxel))
Terminated
- Metastatic Breast Cancer
- ABI-008 (nab-docetaxel)
-
Houston, TexasUniversity of Texas M.D. Anderson Cancer Center
Nov 13, 2019
Metastatic Breast Cancer Trial in Worldwide (Abemaciclib, Nonsteroidal Aromatase Inhibitor (NSAI))
Withdrawn
- Metastatic Breast Cancer
- Abemaciclib
- Nonsteroidal Aromatase Inhibitor (NSAI)
-
Daphne, Alabama
- +118 more
Sep 4, 2019
Metastatic Breast Cancer Trial in Houston (T-DM1, Lapatinib, Abraxane)
Completed
- Metastatic Breast Cancer
- T-DM1
- +2 more
-
Houston, TexasHouston Methodist Hospital
Apr 12, 2019
Breast Tumor, Breast Cancer, Cancer of the Breast Trial in Worldwide (nab-Paclitaxel, Carboplatin, Gemcitabine)
Metastatic Breast Cancer Trial in Worldwide (Fulvestrant, BKM120, BKM120 matching )
Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer Trial in United States (Abraxane alone, Abraxane +
Completed
- Breast Cancer
- +3 more
- Abraxane alone
- Abraxane + Tigatuzumab
-
Birmingham, Alabama
- +9 more
Oct 24, 2017
HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (everolimus, Placebo,
Completed
- HER2/Neu Over-expressing Locally Advanced Breast Cancer
- Metastatic Breast Cancer
- everolimus
- +3 more
-
Tucson, Arizona
- +160 more
Feb 20, 2017
Circulating Tumor Cells From Metastatic Breast Cancer Using
Completed
- Metastatic Breast Cancer
- Blood collection
-
Phoenix, Arizona
- +19 more
Mar 7, 2017
Metastatic Breast Cancer Trial in United States (Ixabepilone, Carboplatin)
Completed
- Metastatic Breast Cancer
-
Phoenix, Arizona
- +58 more
Oct 14, 2016
Metastatic Breast Cancer Trial in United States (Pegylated liposomal doxorubicin, Carboplatin, trastuzumab)
Completed
- Metastatic Breast Cancer
- Pegylated liposomal doxorubicin
- +2 more
-
Birmingham, Alabama
- +56 more
Sep 15, 2016
Advanced Nonhematological Malignancies, NSCLC, Small Cell Lung Cancer Trial in Houston, Salt Lake City (MLN8237 (Alisertib))
Completed
- Advanced Nonhematological Malignancies
- +5 more
- MLN8237 (Alisertib)
-
Houston, Texas
- +1 more
Jul 1, 2016
Metastatic Breast Cancer Trial in United States (Dasatinib, Letrozole)
Completed
- Metastatic Breast Cancer
-
Sedona, Arizona
- +26 more
May 10, 2016
Metastatic Breast Cancer, Tumors, Breast Trial in United States (Investigational Cancer Drug)
Completed
- Metastatic Breast Cancer
- Neoplasms, Breast
- Investigational Cancer Drug
-
Chula Vista, California
- +29 more
Apr 14, 2015
Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (Fulvestrant, Exemestane)
Completed
- Locally Advanced Breast Cancer
- Metastatic Breast Cancer
-
Birmingham, Alabama
- +116 more
Feb 23, 2015
Triple Negative Breast Cancer Biomarker Study
Completed
- Metastatic Breast Cancer
- Triple Negative Breast Cancer
-
Denver, Colorado
- +17 more
Jul 19, 2013
Metastatic Breast Cancer Trial in United States (Trastuzumab emtansine [Kadcyla])
Completed
- Metastatic Breast Cancer
- Trastuzumab emtansine [Kadcyla]
-
Little Rock, Arkansas
- +39 more
Feb 22, 2013